This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992:378:103-9.

Mechanisms of action of BCG in superficial bladder cancer

Affiliations

PMID: 1301570

Review

Mechanisms of action of BCG in superficial bladder cancer

T L Ratliff. Prog Clin Biol Res. 1992.

. 1992:378:103-9.

Author

Affiliation

¹ Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110.

PMID: 1301570

No abstract available

PubMed Disclaimer

Similar articles

Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A. Brandau S, et al. Clin Cancer Res. 2000 Sep;6(9):3729-38. Clin Cancer Res. 2000. PMID: 10999767
Mechanisms of action of intravesical BCG for bladder cancer.
Ratliff TL. Ratliff TL. Prog Clin Biol Res. 1989;310:107-22. Prog Clin Biol Res. 1989. PMID: 2672010 Review.
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
Schreinemachers L, Van der Meyden A, Steerenberg P, Feitz W, Groothuis D, De Jong W, Debruyne F. Schreinemachers L, et al. Chemioterapia. 1987 Jun;6(2 Suppl):713-6. Chemioterapia. 1987. PMID: 3334665 No abstract available.
Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
Zlotta AR, Drowart A, Van Vooren JP, de Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K. Zlotta AR, et al. J Urol. 1997 Feb;157(2):492-8. J Urol. 1997. PMID: 8996341
Theoretical and experimental evidence on the use of glycosaminoglycans in BCG-mediated immunotherapy of superficial bladder cancer.
Schamhart DH, De Boer EC, Vleeming R, Kurth KH. Schamhart DH, et al. Semin Thromb Hemost. 1994;20(3):301-9. doi: 10.1055/s-2007-1001917. Semin Thromb Hemost. 1994. PMID: 7824966 Review. No abstract available.

See all similar articles

Cited by

The quantum of initial transformed cells potentially modulates the type of local inflammation mechanism elicited by surrounding normal epithelial tissues and systemic immune pattern for tumor arrest or progression.
Owusu L, Wang B, Du Y, Li W, Xin Y. Owusu L, et al. J Cancer. 2015 Jan 1;6(2):128-38. doi: 10.7150/jca.10787. eCollection 2015. J Cancer. 2015. PMID: 25561977 Free PMC article.
Proteoglycans and glycosaminoglycans in tumor growth and migration: first experience with tumors of bladder and prostate origin.
Schamhart DH, Kurth KH. Schamhart DH, et al. World J Urol. 1994;12(1):55-61. doi: 10.1007/BF00182053. World J Urol. 1994. PMID: 8012417 Review.
Interaction between bacteria and the lumenal bladder surface: modulation by pentosan polysulfate, an experimental and theoretical approach with clinical implication.
Schamhart DH, de Boer EC, Kurth KH. Schamhart DH, et al. World J Urol. 1994;12(1):27-37. doi: 10.1007/BF00182048. World J Urol. 1994. PMID: 7516779
Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer.
Patard JJ, Chopin DK, Boccon-Gibod L. Patard JJ, et al. World J Urol. 1993;11(3):165-8. doi: 10.1007/BF00211413. World J Urol. 1993. PMID: 8401636 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information